TY - JOUR
T1 - Synthesis and Characterization of Curcumin Incorporated Multi Compo-nent Nano-Scaffold with Enhanced Anti‐bacterial and Wound Healing Properties
AU - Wu, Yi Ying
AU - Kumar, Ramya
AU - Wong, Chi Cheng
AU - Reddy, Desu Naveen Kumar
AU - Huang, Fu Yung
N1 - Funding Information:
This study was supported financially by the Department of Chemistry (Grant No. B110-K569), National Cheng Kung University, Tainan, Taiwan. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.
Publisher Copyright:
© 2023 Bentham Science Publishers.
PY - 2023/5
Y1 - 2023/5
N2 - Background: Wound healing is one of the major challenges in chronic diseases; the current treatment options are less effective with undesirable side effects and are expensive. Extensive research is carried out to develop cost-effective, natural, biodegradable wound dressings that can reduce oxida-tive stress and inflammation and prevent bacterial infections. Curcumin has a plethora of therapeutic applications; however, its low solubility limits its clinical use. Objective: In this study, curcumin nanoparticles (Cur NP) and curcumin-chitosan nanoparticles (CCNP) were incorporated into the chitosan collagen vanillin scaffold, characterized, and investigated their potential wound healing properties. Methods: The nano-scaffolds were prepared by freeze-drying method and were characterized using Fourier transform infrared spectroscopy, X-ray diffraction, nanoparticle tracking analysis, and scanning electron microscopy. The drug release, antioxidant, antibacterial, and wound healing properties were assessed by in vitro assays. Results: Cur nano-scaffolds showed particle sizes of 195.9 nm and 110.6 nm for Cur NP+VC and CCNP+VC, respectively. The curcumin encapsulated in the Cur NP+VC and CC+VC nano-scaffolds showed a release profile of > 60% and an improved antioxidant activity of greater than 80%. The nano-scaffolds were antagonistic against Escherichia coli and Staphylococcus aureus and enhanced wound healing capacity of 85.62 % and 77.05% in the murine cell line. Conclusion: The curcumin nano-scaffold is a biodegradable and effective drug delivery system for topical use that can act as an antioxidant, facilitate wound healing, as well as prevent bacterial infec-tions.
AB - Background: Wound healing is one of the major challenges in chronic diseases; the current treatment options are less effective with undesirable side effects and are expensive. Extensive research is carried out to develop cost-effective, natural, biodegradable wound dressings that can reduce oxida-tive stress and inflammation and prevent bacterial infections. Curcumin has a plethora of therapeutic applications; however, its low solubility limits its clinical use. Objective: In this study, curcumin nanoparticles (Cur NP) and curcumin-chitosan nanoparticles (CCNP) were incorporated into the chitosan collagen vanillin scaffold, characterized, and investigated their potential wound healing properties. Methods: The nano-scaffolds were prepared by freeze-drying method and were characterized using Fourier transform infrared spectroscopy, X-ray diffraction, nanoparticle tracking analysis, and scanning electron microscopy. The drug release, antioxidant, antibacterial, and wound healing properties were assessed by in vitro assays. Results: Cur nano-scaffolds showed particle sizes of 195.9 nm and 110.6 nm for Cur NP+VC and CCNP+VC, respectively. The curcumin encapsulated in the Cur NP+VC and CC+VC nano-scaffolds showed a release profile of > 60% and an improved antioxidant activity of greater than 80%. The nano-scaffolds were antagonistic against Escherichia coli and Staphylococcus aureus and enhanced wound healing capacity of 85.62 % and 77.05% in the murine cell line. Conclusion: The curcumin nano-scaffold is a biodegradable and effective drug delivery system for topical use that can act as an antioxidant, facilitate wound healing, as well as prevent bacterial infec-tions.
UR - http://www.scopus.com/inward/record.url?scp=85147179812&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147179812&partnerID=8YFLogxK
U2 - 10.2174/1567201819666220414092342
DO - 10.2174/1567201819666220414092342
M3 - Article
C2 - 35430990
AN - SCOPUS:85147179812
SN - 1567-2018
VL - 20
SP - 400
EP - 413
JO - Current Drug Delivery
JF - Current Drug Delivery
IS - 4
ER -